Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone for Acute Pain in IBD Surgery
NCT03422861Unknown
- Sponsor
- Mount Sinai Hospital
- Start
- Dec 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in acute pain and inflammatory bowel disease (IBD) comparing Nabilone Treatment with Placebo Treatment (2 arms). Primary endpoint: Total amount of opioid consumption postoperatively at 72 hours. Status: unknown.
02
Drugs
nabilone
03
Conditions
acute paininflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT03422861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422861.